Nanovaccines have gathered significant attention for their potential to elicit tumor-specific
immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines …

Liposomes can greatly improve the pharmacokinetics of therapeutic agents due to their
ability to encapsulate drugs and accumulate in target tissues. Considerable effort has been …

Nanoparticles have the potential to improve disease treatment and diagnosis due to their
ability to incorporate drugs, alter pharmacokinetics, and enable tissue targeting. While …

The induction of durable protective immune responses is the main goal of prophylactic
vaccines, and adjuvants play an important role as drivers of such responses. Despite …

The efficacy of cell therapy is compromised by the suboptimal survival and function of
transplanted cells, which can be partly attributed to uncontrolled immunomodulation. To …

With increasing progress in the life sciences, we are now able to treat diseases that were
previously deemed incurable. This progress, however, comes with new challenges due to …